Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Regulation

Ex-FDA officials: EUA may be merited, but FDA put politics ahead of science

Former senior agency officials say Hahn prioritized politics in authorizing COVID-19 convalescent plasma

By steve usdin, washington editor
August 24, 2020 2:04 AM UTC
Updated on Aug 29, 2020 at 3:25 AM UTC
Editor's note: This story has been updated to reflect comments by FDA Commissioner Stephen Hahn.

FDA Commissioner Stephen Hahn’s decisions and comments about granting Emergency Use Authorization for convalescent plasma to treat COVID-19 have put politics ahead of science, former senior FDA officials told BioCentury.

“At this moment in time, the FDA can no longer call itself an independent and science-based regulatory agency,” Luciana Borio, former acting FDA chief scientist, told BioCentury. ...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Mayo Clinic

U.S. Food and Drug Administration (FDA)